文献速递血液净化与透析

美国血液透析滤过(HDF)的监管考量

Regulatory Considerations for Hemodiafiltration in the United States.
PubMed 文献 · Clin J Am Soc Nephrol · 2018-03-06

本文讨论在线血液透析滤过(HDF)在美国的监管路径与挑战。HDF对高分子量尿毒症溶质清除优于高通量血透,但美国因缺乏获FDA批准的输送系统而应用稀少。监管关注在线制备大量无菌无热原置换液的安全验证,明确测试方案有助证明系统可达10^-6无菌保证水平及无热原内毒素水平。

要点

  • HDF对高分子量尿毒症溶质清除优于常规高通量血透,但美国应用受限于FDA批准的输送系统不足。
  • 监管核心关注在线制备大量无菌无热原置换液的安全性与验证方法。
  • 大规模临床经验显示,具备冗余设计及质量管理体系的系统可常规安全制备置换液。

核心结论

  • 在线HDF在美国有监管审批路径,但在线制备无菌无热原置换液仍是主要监管关切。

主要发现

  • 在线HDF对高分子量尿毒症溶质清除优于常规高通量血透。
  • 美国在线HDF应用稀少,部分原因是缺乏获FDA批准用于临床的输送系统。
  • 大规模临床经验表明,具备冗余设计和适当质量管理流程的系统可常规安全制备置换液。

关键数值与推荐

  • 明确且获FDA接受的测试方案可用于证明在线HDF系统能常规达到10^-6无菌保证水平和无热原内毒素水平。

临床怎么用

  • 肾内科医生应了解在线HDF的监管现状及置换液无菌无热原验证要求。
  • 临床引入在线HDF系统时需关注冗余设计和质量管理流程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Online hemodiafiltration provides greater removal of higher molecular weight uremic retention solutes than conventional high-flux hemodialysis. However, online hemodiafiltration is used sparsely in the United States in part because of a paucity of delivery systems cleared for clinical use by the US Food and Drug Administration. Although a pathway for regulatory approval exists in the United States, concerns remain, particularly regarding online production of the large volumes of sterile, nonpyrogenic substitution fluid infused directly into the bloodstream to maintain fluid balance. Clearly defined testing protocols, acceptable to Food and Drug Administration, will be useful to show that an online hemodiafiltration system is capable of routinely achieving a sterility assurance level of 10-6 and nonpyrogenic levels of endotoxin. Large-scale clinical experience has shown that systems providing this level of performance when combined with certain design features, such as redundancy, and an appropriate quality management process can routinely and safely produce substitution fluid for online hemodiafiltration.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ward RA, Vienken J, Silverstein DM, et al. Regulatory Considerations for Hemodiafiltration in the United States. Clin J Am Soc Nephrol. 2018. PMID: 29511058. doi:10.2215/CJN.12641117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。